SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-21-020209
Filing Date
2021-08-16
Accepted
2021-08-16 16:40:52
Documents
6

Document Format Files

Seq Description Document Type Size
1 formposam.htm POS AM 134845
2 ex5-1.htm EX-5.1 26209
3 ex23-1.htm EX-23.1 5500
4 ex5-1_001.jpg GRAPHIC 3359
5 ex5-1_002.jpg GRAPHIC 3128
6 ex23-1_001.jpg GRAPHIC 2314
  Complete submission text file 0001493152-21-020209.txt   180117
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-258854 | Film No.: 211179122
SIC: 2834 Pharmaceutical Preparations